Company guidance, FDA catalysts, dilution risk and cash runway, built from SEC, FDA and ClinicalTrials.gov filings and updated every day.
We send one confirmation email first. Only emails about FMS, unsubscribe in one click. Privacy
| Drug | Indication | Most advanced trial | Status |
|---|---|---|---|
| SMOFlipid® (lipid injectable emulsion) | Malnutrition, Child | Phase 4 · NCT06049680 | Recruiting |
| Difelikefalin Injection | Uremic Pruritus | Phase 3 · NCT05885737 | Completed |
| FKS518 | Postmenopausal Osteoporosis | Phase 3 · NCT04934072 | Completed |
| Patiromer Powder for Oral Suspension (Pa | Hyperkalemia | Phase 3 · NCT05136664 | Completed |
| Patiromer Powder for Orals Suspension (P | Hyperkalemia | Phase 3 · NCT05136664 | Completed |
| US-licensed Prolia (Amgen) | Postmenopausal Osteoporosis | Phase 3 · NCT04934072 | Completed |
| adult donor RBC concentrates | Retinopathy of Prematurity | Phase 2 · NCT05100212 | Completed |
| cord blood-RBC concentrates | Retinopathy of Prematurity | Phase 2 · NCT05100212 | Completed |
| Difelikefalin | Pruritus | Phase 2 · NCT06593392 | Recruiting |
| Fresubin Supportan | Head &Amp;Amp; Neck Squamous Cell Carcinoma | Phase 1/2 · NCT07180576 | Not yet recruiting |
| Tocilizumab | Calcium Pyrophosphate Deposition Disease | Phase 2 · NCT07254637 | Not yet recruiting |
| Omegaven® (fish oil triglycerides) Injec | Parenteral Nutrition Associated Liver Disease (PNA | N/A · NCT06274788 | Recruiting |
Source: ClinicalTrials.gov trials sponsored by the company, one row per candidate at its most advanced registered trial. FDA approvals: Drugs@FDA. Wrong or missing drug? Report it
FMS holds $1.1B in cash and short-term investments and its operations are currently cash-flow neutral or positive.
Dilution pressure: 0 · Low
Source: SEC EDGAR (XBRL cash flow and financing filings). Dilution Watch: every company ranked → · Get an alert when FMS files for a raise →
The 7-day free trial adds AI daily briefings, sentiment tracking, trial enrollment progress and email alerts for FMS and every other ticker you follow. Card required, cancel anytime.
Start 7-day free trial →